Reflow Medical, Inc : Reflow Medical Receives CE Mark for Bare Temporary Spur Stent System for Treating de novo or Restenotic Below-the-Knee (BTK) Lesions finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Results from five clinical trials were presented during the VIVA (Vascular InterVentional Advances) Conference, VIVA23, providing outcomes from studies on treatment for chronic limb-threatening ischemia (CLTI), use of drug-coated balloons, among other highly-anticipated late-breaking science findings.
/PRNewswire/ The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and.
First Round of Late-Breaking Clinical Trial Results Announced at VIVA23 kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.